Sanit Wichansawakun

Prof. Sanit Wichansawakun


Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 January 2024 in Nutrients
Verified
Journal Article
Open access
PDF file
PNPornpimon Nunthanawanich
Pornpimon Nunthanawanich
SWSanit Wichansawakun
Sanit Wichansawakun
Cholrit LuangjindaCholrit Luangjinda
Cholrit Luangjinda
CHChatrapa Hudthagosol
Chatrapa Hudthagosol
The most common cancer in Thailand is colorectal cancer (CRC). A lack of knowledge and misleading information from social media have contributed to cancer deaths from malnutrition. A web application is a tool that provides easy access to scientific nutritional information via an online platform. In this study, our goal was to compare the nutritional status of CRC patients using different nutrition-based educational tools with nutrition counseling, namely the Nutrition Educational Prototype based on Smartphone Web Applications (NEPSA) and standard hospital leaflets. Anthropometric and biochemical analyses and a dietary assessment, especially calories and protein, were measured during three visits. This study finally included 28 CRC patients who were undergoing chemotherapy and malnutrition with a body mass index (BMI) of <20 kg/m2. Thirteen participants received NEPSA while the remaining fifteen participants received a standard hospital leaflet. The results showed that NEPSAs improved nutritional outcomes by encouraging weight gain, increasing BMI, hemoglobin, hematocrit, and albumin levels, and consuming more calories and protein. NEPSA should be implemented to enhance the nutrition outcomes from anthropometric, biochemical, and dietary perspectives from nutrition advice among CRC patients. There could be positive impacts at the national level regarding equal accessibility to Thailand’s nutrition information.

26 March 2014
Verified
Book Chapter
Closed access
PDF file
SWSanit Wichansawakun
Sanit Wichansawakun
DKDong Wook Kim
Dong Wook Kim
LYLorraine S. Young
Lorraine S. Young
CACaroline M. Apovian
Caroline M. Apovian

27 October 2026 in BMC Nutrition
Verified
Journal Article
Open access
PDF file
KCKanokkarn Chupisanyarote
Kanokkarn Chupisanyarote
WSWanwipa Srikhajonjit
Wanwipa Srikhajonjit
NKNutchaya Kullavanijaya
Nutchaya Kullavanijaya
CSChomchanok Srichan
Chomchanok Srichan
JTJutamat Tonglim
Jutamat Tonglim
SWSanit Wichansawakun
Sanit Wichansawakun
Background: Type 2 diabetes mellitus (T2DM) is a major and growing health burden in Asia, where maintaining glycemic control remains challenging because of high refined carbohydrate consumption and rapid dietary transitions. Evidence from randomized controlled trials evaluating culturally adapted low–glycemic index (GI) diabetes-specific formulas (DSFs) in Asian outpatient settings remains limited. This study evaluated the effect of a low-GI DSF (GI 26; D-care) used as a once-daily meal replacement on glycemic control and metabolic parameters in Thai adults with T2DM. Methods: A total of 102 adults with T2DM (aged 35–75 years) were randomly assigned to a control group receiving standard nutrition advice (CT, n = 51) or an intervention group receiving standard nutrition advice plus one daily DSF meal replacement (DC, n = 51) for 90 days. Outcomes were analyzed using linear mixed-effects models to assess time, group, and time × group interaction effects. Results: Compared with the CT group, the DC group showed a significantly greater reduction in HbA1c (adjusted mean difference − 0.34%, 95% CI − 0.6 to − 0.1; p = 0.020). Reductions in fasting blood glucose, triglycerides, body weight, and daily energy intake were observed in the DC group; however, these changes were not significantly different between groups. Conclusion: Once-daily use of a low-GI diabetes-specific formula as part of standard nutritional counseling was associated with improved glycemic control in Thai adults with T2DM. This strategy may represent a practical dietary approach for diabetes management in Asian populations. Trial registration: Thai Clinical Trials Registry (TCTR20230122001), registered on 22 January 2023.